Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shujun Ye, Saimei Hua & Meiyang Zhou. (2022) Transient B-cell depletion and regulatory T-cells mediation in combination with adenovirus mediated IGF-1 prevents and reverses autoimmune diabetes in NOD mice. Autoimmunity 55:8, pages 529-537.
Read now
Read now
Zheng Li, Qianqian Qiu, Xinqian Geng, Jianyong Yang, Wenlong Huang & Hai Qian. (2016) Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development. Expert Opinion on Investigational Drugs 25:8, pages 871-890.
Read now
Read now
Articles from other publishers (40)
Bibi Fatima, Faiza Saleem, Uzma Salar, Sridevi Chigurupati, Shatha G. Felemban, Zaheer Ul‐Haq, Syeda S. Tariq, Suliman A. Almahmoud, Muhammad Taha, Syed T. A. Shah & Khalid M. Khan. (2023) Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4‐oxadiazole derivatives: Synthesis, in vitro screening, and computational studies. Archiv der Pharmazie 356:12.
Crossref
Crossref
Rafaqat Hussain, Wajid Rehman, Shoaib Khan, Aneela Maalik, Mohamed Hefnawy, Ashwag S. Alanazi, Yousaf Khan & Liaqat Rasheed. (2023) Imidazopyridine-Based Thiazole Derivatives as Potential Antidiabetic Agents: Synthesis, In Vitro Bioactivity, and In Silico Molecular Modeling Approach. Pharmaceuticals 16:9, pages 1288.
Crossref
Crossref
Yuting Hao, Hao Zhang, Xizhuang Yue, Zhen Zhao & Shuang Zhao. (2023) A novel electrochemical sensor based on Cu(Ⅱ) metal organic framework for the determination of metformin. Microchemical Journal 191, pages 108849.
Crossref
Crossref
Zheng Li, Lianru Chen & Luyong Zhang. 2023. Privileged Scaffolds in Drug Discovery. Privileged Scaffolds in Drug Discovery
357
375
.
Xin Zhang, Erwin Kupczyk, Philippe Schmitt-Kopplin & Constanze Mueller. (2022) Current and future approaches for in vitro hit discovery in diabetes mellitus. Drug Discovery Today 27:10, pages 103331.
Crossref
Crossref
Mandeep Kaur & Raj Kaushal. (2022) Synthesis and in-silico molecular modelling, DFT studies, antiradical and antihyperglycemic activity of novel vanadyl complexes based on chalcone derivatives. Journal of Molecular Structure 1252, pages 132176.
Crossref
Crossref
Zongtao Zhou, Zongyu Cai, Congzi Zhang, Benhui Yang, Lianru Chen, Yepu He, Luyong Zhang & Zheng Li. (2022) Design, synthesis, and biological evaluation of novel dual FFA1 and PPARδ agonists possessing phenoxyacetic acid scaffold. Bioorganic & Medicinal Chemistry 56, pages 116615.
Crossref
Crossref
Isaac John Umaru, Maryam Usman Ahme, Bilyaminu Habibu, Imaranezor Kenneth, Philip Shadrach & Muhammad Zuhairah I. (2022) Protective Role of Solandra longiflora Flower Extracts on Streptozotocin Diabetes Induced Albino Rats. Asian Journal of Biochemistry 17:1, pages 7-14.
Crossref
Crossref
Guang-Zhen Wan, Xiao-Hui Ma, Ling Jin & Juan Chen. (2021) α-glucosidase immobilization on magnetic core-shell metal-organic frameworks for inhibitor screening from traditional Chinese medicines. Colloids and Surfaces B: Biointerfaces 205, pages 111847.
Crossref
Crossref
Wei Ge, Benhui Yang, Lianru Chen, Zongtao Zhou & Yao Jin. (2021) Discovery of Novel G‐Protein‐Coupled Receptor 40 Agonist with Phenylacetic Acid Scaffold for the Treatment of Type 2 Diabetes. ChemistrySelect 6:29, pages 7372-7375.
Crossref
Crossref
Azadeh Ebrahim-Habibi, Elaheh Kashani-Amin & Bagher Larijani. (2021) Modeling and simulation in medical sciences: an overview of specific applications based on research experience in EMRI (Endocrinology and Metabolism Research Institute of Tehran University of Medical Sciences). Journal of Diabetes & Metabolic Disorders.
Crossref
Crossref
Charalampos Loutradis, Eirini Papadopoulou, Elena Angeloudi, Asterios Karagiannis & Pantelis Sarafidis. (2020) The Beneficial Hemodynamic Actions of SGLT-2 Inhibitors beyond the Management of Hyperglycemia. Current Medicinal Chemistry 27:39, pages 6682-6702.
Crossref
Crossref
Xin Wang, Jinhong Kang, Qing Liu, Tao Tong & Helong Quan. (2020) Fighting Diabetes Mellitus: Pharmacological and Non-pharmacological Approaches. Current Pharmaceutical Design 26:39, pages 4992-5001.
Crossref
Crossref
Yumin Wu, Tiemei Ji, Jie Lv & Zhicun Wang. (2020) Rapid selection of a novel GLP-1/GIP dual receptor agonist with prolonged glycemic control and weight loss in rodent animals. Life Sciences 257, pages 118025.
Crossref
Crossref
Yueming Chen, Qiang Ren, Zongtao Zhou, Liming Deng, Lijun Hu, Luyong Zhang & Zheng Li. (2020)
HWL‐088, a new potent free fatty acid receptor 1 (FFAR1) agonist, improves glucolipid metabolism and acts additively with metformin in
ob/ob
diabetic mice
. British Journal of Pharmacology 177:10, pages 2286-2302.
Crossref
Crossref
Zheng Li, Chunxia Liu, Zongtao Zhou, Lijun Hu, Liming Deng, Qiang Ren & Hai Qian. (2020) A novel FFA1 agonist, CPU025, improves glucose-lipid metabolism and alleviates fatty liver in obese-diabetic (ob/ob) mice. Pharmacological Research 153, pages 104679.
Crossref
Crossref
Maorong Wang, Ping Yao, Minpeng Gao, Jian Jin & Yerong Yu. (2020) Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites. RSC Advances 10:14, pages 8044-8053.
Crossref
Crossref
Alireza Barmak, Khodabakhsh Niknam & Gholamhossein Mohebbi. (2019)
Synthesis, Structural Studies, and α-Glucosidase Inhibitory, Antidiabetic, and Antioxidant Activities of 2,3-Dihydroquinazolin-4(1
H
)-ones Derived from Pyrazol-4-carbaldehyde and Anilines
. ACS Omega 4:19, pages 18087-18099.
Crossref
Crossref
Zheng Li, Lijun Hu, Xuekun Wang, Zongtao Zhou, Liming Deng, Yawen Xu & Luyong Zhang. (2019) Design, synthesis, and biological evaluation of novel dual FFA1 (GPR40)/PPARδ agonists as potential anti-diabetic agents. Bioorganic Chemistry 92, pages 103254.
Crossref
Crossref
Charalampos Loutradis, Eirini Papadopoulou, Marietta Theodorakopoulou, Asterios Karagiannis & Pantelis Sarafidis. (2019) The effect of SGLT-2 inhibitors on blood pressure: a pleiotropic action favoring cardio- and nephroprotection. Future Medicinal Chemistry 11:11, pages 1285-1303.
Crossref
Crossref
Jiaju Yang, Enke Gu, Ting Yan, Daoming Shen, Bainian Feng & Chunlei Tang. (2019) Design, synthesis, and evaluation of a series of novel phenylpropanoic acid derivatives agonists for the FFA1. Chemical Biology & Drug Design 93:5, pages 900-909.
Crossref
Crossref
Deyu Kong, Shimeng Guo, Yushe Yang, Bin Guo, Xin Xie & Wenhao Hu. (2019) Synthesis and biological evaluation of novel potent FFA1 agonists containing 2,3-dihydrobenzo[b][1,4]dioxine. Bioorganic & Medicinal Chemistry Letters 29:6, pages 848-852.
Crossref
Crossref
Zheng Li, Yueming Chen, Zongtao Zhou, Liming Deng, Yawen Xu, Lijun Hu, Bing Liu & Luyong Zhang. (2019) Discovery of first-in-class thiazole-based dual FFA1/PPARδ agonists as potential anti-diabetic agents. European Journal of Medicinal Chemistry 164, pages 352-365.
Crossref
Crossref
Tingting Zhou, Mengfan Du, Tong Zhao, Lingling Quan, Zhiyuan Zhu & Jing Chen. (2018) ETA as a novel Kv2.1 inhibitor ameliorates β‐cell dysfunction and hyperglycaemia. Clinical and Experimental Pharmacology and Physiology 45:12, pages 1257-1264.
Crossref
Crossref
Bin Guo, Shimeng Guo, Jing Huang, Jingya Li, Jia Li, Qian Chen, Xianli Zhou, Xin Xie & Yushe Yang. (2018) Design and optimization of 2,3-dihydrobenzo[b][1,4]dioxine propanoic acids as novel GPR40 agonists with improved pharmacokinetic and safety profiles. Bioorganic & Medicinal Chemistry 26:22, pages 5780-5791.
Crossref
Crossref
Jonathan Emeka Emordi, Esther Oluwatoyin Agbaje, Ibrahim Adekunle Oreagba & Osede Ignis Iribhogbe. (2018)
Antidiabetic Effects of the Ethanolic Root Extract of
Uvaria chamae
P. Beauv (Annonaceae) in Alloxan-Induced Diabetic Rats: A Potential Alternative Treatment for Diabetes Mellitus
. Advances in Pharmacological Sciences 2018, pages 1-13.
Crossref
Crossref
Zheng Li, Zongtao Zhou, Fengjian Deng, Yuyi Li, Danjun Zhang & Luyong Zhang. (2018) Design, synthesis, and biological evaluation of novel pan agonists of FFA1, PPARγ and PPARδ. European Journal of Medicinal Chemistry 159, pages 267-276.
Crossref
Crossref
Tingting Zhou, Xin Xu, Mengfan Du, Tong Zhao & Jiaying Wang. (2018) A preclinical overview of metformin for the treatment of type 2 diabetes. Biomedicine & Pharmacotherapy 106, pages 1227-1235.
Crossref
Crossref
Zheng Li, Yueming Chen, Yuhan Zhang, Hongwei Jiang, Yanzhi Liu, Yufang Chen, Luyong Zhang & Hai Qian. (2018) Structure-based design of free fatty acid receptor 1 agonists bearing non-biphenyl scaffold. Bioorganic Chemistry 80, pages 296-302.
Crossref
Crossref
Fei Ma, Jian Liu, Tingting Zhou, Min Lei, Jing Chen, Xiachang Wang, Yinan Zhang, Xu Shen & Lihong Hu. (2018) Discovery and structure-activity relationships study of thieno[2,3-b]pyridine analogues as hepatic gluconeogenesis inhibitors. European Journal of Medicinal Chemistry 152, pages 307-317.
Crossref
Crossref
Tingting Zhou, Yanhua Cheng, Wenzhong Yan, Xiaofan Shi, Xin Xu, Jinpei Zhou, Jian Li, Jing Chen & Xu Shen. (2018) TSPA as a novel ATF6α translocation inducer efficiently ameliorates insulin sensitivity restoration and glucose homeostasis in db/db mice. Biochemical and Biophysical Research Communications 499:4, pages 948-953.
Crossref
Crossref
Zheng Li, Xue Xu, Jie Hou, Shaohong Wang, Hongwei Jiang & Luyong Zhang. (2018) Structure-based optimization of free fatty acid receptor 1 agonists bearing thiazole scaffold. Bioorganic Chemistry 77, pages 429-435.
Crossref
Crossref
Joana Reis, Alexandra Gaspar, Nuno Milhazes & Fernanda Borges. (2017) Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances. Journal of Medicinal Chemistry 60:19, pages 7941-7957.
Crossref
Crossref
Zheng Li, Chunxia Liu, Xue Xu, Qianqian Qiu, Xin Su, Yuxuan Dai, Jianyong Yang, Huilan Li, Wei Shi, Chen Liao, Miaobo Pan, Wenlong Huang & Hai Qian. (2017) Discovery of phenylsulfonyl acetic acid derivatives with improved efficacy and safety as potent free fatty acid receptor 1 agonists for the treatment of type 2 diabetes. European Journal of Medicinal Chemistry 138, pages 458-479.
Crossref
Crossref
Ting-Ting Zhou, Fei Ma, Xiao-Fan Shi, Xin Xu, Te Du, Xiao-Dan Guo, Gai-Hong Wang, Liang Yu, Vatcharin Rukachaisirikul, Li-Hong Hu, Jing Chen & Xu Shen. (2017) DMT efficiently inhibits hepatic gluconeogenesis by regulating the Gαq signaling pathway. Journal of Molecular Endocrinology 59:2, pages 151-169.
Crossref
Crossref
Jianyong Yang, Zheng Li, Huilan Li, Chunxia Liu, Nasi Wang, Wei Shi, Chen Liao, Xingguang Cai, Wenlong Huang & Hai Qian. (2017) Design, synthesis and structure–activity relationship studies of novel free fatty acid receptor 1 agonists bearing amide linker. Bioorganic & Medicinal Chemistry 25:8, pages 2445-2450.
Crossref
Crossref
Zheng Li, Jianyong Yang, Xuekun Wang, Huilan Li, Chunxia Liu, Nasi Wang, Wenlong Huang & Hai Qian. (2016) Discovery of novel free fatty acid receptor 1 agonists bearing triazole core via click chemistry. Bioorganic & Medicinal Chemistry 24:21, pages 5449-5454.
Crossref
Crossref
T T Zhou, L L Quan, L P Chen, T Du, K X Sun, J C Zhang, L Yu, Y Li, P Wan, L L Chen, B H Jiang, L H Hu, J Chen & X Shen. (2016) SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathways. Cell Death & Disease 7:5, pages e2216-e2216.
Crossref
Crossref
Zheng Li, Qianqian Qiu, Xue Xu, Xuekun Wang, Lei Jiao, Xin Su, Miaobo Pan, Wenlong Huang & Hai Qian. (2016) Design, synthesis and Structure–activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes. European Journal of Medicinal Chemistry 113, pages 246-257.
Crossref
Crossref
Zheng Li, Jianyong Yang, Weijie Gu, Guoshen Cao, Xiaoting Fu, Xuedan Sun, Yu Zhang, Hui Jin, Wenlong Huang & Hai Qian. (2016) Discovery of a novel oxime ether scaffold as potent and orally bioavailable free fatty acid receptor 1 agonists. RSC Advances 6:52, pages 46356-46365.
Crossref
Crossref